D&A Pharma Information

D&A PHARMA is a Specialty Pharma committed to providing effective and innovative treatments to patients suffering from various addictions (alcohol, opiates, cocaine…). In 2017, the treatment of alcohol and cocaine dependences is still an unmet medical need with more than 100 million patients worldwide suffering from their addictions, developing serious attributable diseases and creating significant burden. D&A PHARMA lead product, ALCOVER, is targeting the treatment of alcohol-dependent patients with a Very High Drinking Risk Level (daily alcohol consumption > 60g for women and > 100g for men). Life expectancy in this population is estimated at only 47 to 61 years, underlying the urgency to treat these patients. ALCOVER has shown to be effective and safe in both the detoxification phase and the long-term maintenance of alcohol abstinence with unprecedented efficacy results in this population. ALCOVER is approved in Italy and Austria and registration is ongoing in 10 other EU countries. Two other pharmacotherapies aiming at treating opiate and cocaine addictions respectively are under development with promising results. Our Culture, Values and Company’s size foster a fast-paced, dynamic, forward-thinking, friendly and team-working environment. Look at our job opportunities and join us!